Skip to main content
. Author manuscript; available in PMC: 2011 Jul 22.
Published in final edited form as: Oncogene. 2010 Dec 20;30(14):1615–1630. doi: 10.1038/onc.2010.566

Figure 2.

Figure 2

Sites of modification in p65 (RelA) subunit of NF-κB in cancer. Locations of various modification sites in the Rel homology domain and transactivation domains (TAD1 and 2) of p65 are shown. The possible effects are shown in the boxes. Ac, actylation; K, lysine residues; M, methylation; P, phosphorylation; S, serine residues; Ub, ubiquitination.